Previous 10 | Next 10 |
2023-09-26 08:45:42 ET Palm Beach, FL – September 26, 2023 – FinancialNewsMedia.com News Commentary – There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid increase in the prevalence of cancer cases and its gr...
2023-09-26 07:30:39 ET More on Oncolytics Biotech Seeking Alpha’s Quant Rating on Oncolytics Biotech Oncolytics Biotech: Is The Early Data Really That Good? Oncolytics: Proof Of Concept In 2 Large Market Indications Oncolytics Biotech: Back In The Spot...
THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS Canada NewsWire Innovative Multimillion-Dollar Grant Was Created in 2022 to Drive Biopharma Industry to Speed Dev...
2023-09-22 10:15:25 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal , optimism in the b...
2023-09-20 11:40:13 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their &...
2023-09-19 12:25:41 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 19, 2023 – USA News Group – A new cancer-focused venture capital firm is making headlines, having debuted with $200 million in funding f...
Oncolytics Biotech® Announces Fireside Chat at the Cantor Global Healthcare Conference PR Newswire SAN DIEGO and CALGARY, AB , Sept. 19, 2023 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherap...
2023-09-13 11:01:24 ET Summary Oncolytics Biotech is developing an oncolytic virus for solid tumor treatment, but the small patient populations make it difficult to determine the effectiveness. The company's main developmental project is pelareorep, a reovirus that infects cancer ...
2023-09-13 09:00:30 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food and Drug Administr...
Oncolytics Biotech® Announces Full Exercise of Over-Allotment Option from Public Offering Canada NewsWire CALGARY, AB , Sept. 7, 2023 /CNW/ -- Oncolytics Biotech ® Inc. (" Oncolytics " or the " Company ") (NASDAQ: ONCY) (TSX: ONC) today anno...
News, Short Squeeze, Breakout and More Instantly...
Oncolytics Biotech Inc. Company Name:
ONCY Stock Symbol:
NASDAQ Market:
Oncolytics Biotech Inc. Website:
Oncolytics Biotech® Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program Canada NewsWire Clear path forward on key elements of the planned potential registration-enabling trial in HR+/HER2- metastatic breast cancer On track to report ove...
Oncolytics Biotech® Announces President and Chief Executive Officer Dr. Matt Coffey to Take Medical Leave of Absence Canada NewsWire Wayne Pisano , Chair of Oncolytics' Board of Directors, to serve as interim CEO Overall Survival data from BRACELET-1 breast ca...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...